Advisory Services: Healthcare
Market Analysis & Research
Detection of attractive market segments
Our healthcare industry insight enables us to efficiently identify the most attractive market segments and ideal growth areas according to the clients' capabilities and requirements. While comparing the attractiveness of one market compared to another a wide range of criteria has to be applied. ConAlliance helps to prioritise potential markets and creates transparency in determining, whether a market is attractive to enter.
Market Analysis Research
ConAlliance market analysis research provides important information to identify and analyse the market criteria, market size, market segmentation, market potential, market competition and market trends.
ConAlliance delivers the basis for management decisions through product concepts combined with early transparency of user acceptance by identification and ranking of customer needs, comprehensive segmentation, advantages of alternates and competing products, uncovering of risks and estimation of contribution margin of the product concept.
Valuation and prioritization
We identify ideal applications for existing technologies/products and determine the fair value of innovative products, product portfolios or entire companies.
ConAlliance conducts
customer analysis,
competitor analysis and
country analysis.
We provide independent, accurate, comprehensive, and up to date research on global healthcare and life sciences industries, including statistics, analysis and forecasts.
Quicklinks
Business development
Direct market assessment
Technology target scouting
Quickcontact
Please contact your expert
in healthcare investment banking and M&A advisory
CONALLIANCE PROVIDES COMMERCIAL DUE DILIGENCE FOR THE PRIVATE EQUITY MID- MARKET STRATEGY SUPPORT FOR PORTFOLIO BUSINESS
Conalliance provides financial advice on a wide range of mergers and acquisitions and capital raising activities such as mergers, acquisitions, divestitures, joint ventures, licensing, joint ventures. As a leading M&A advisory firm, our teams provide bespoke investment banking solutions for the healthcare industry sector. Our sector M&A consultants are based at the main hubs (London, Hong Kong, Munich, Copenhagen, Chicago and New York), providing clients with coverage on a global and regional basis.
According to recent surveys Conalliance are amongst the leading mergers acquisitions advisory firms in the health care and life sciences industries. Conalliance have a significant track record of health care cross border transactions. Conalliance does not publish transactions and thombstones for confidentiality reasons.
We offer a full spectrum of buy- and sell-side advisory services often working with entrepreneurs, private equity backed businesses and public companies. Services include identifying key strategic buyers, negotiation to maintain competitive tension between potential buyers, general project management and deal execution. The Conalliance M&A team also assist private equity firms and corporate development teams to source acquisition opportunities. Buy-side advisory services include identifying and analysing targets, providing guidance on valuation and negotiation of terms. We have end-to-end capabilities, from initial screening to value acceleration to synergy realization after the acquisition. Our research-driven methodology enables us to conduct thorough commercial due diligence in real time. We also help clients identify the true value of an opportunity by combining our meticulous financial analysis with the deep industry knowledge required to understand how the shifting market landscape can impact potential deals.
